Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/ mismatch repair–deficient cancer: Results from the phase II KEYNOTE-158 study

Aurelien Marabelle, Dung T. Le, Paolo A. Ascierto, Anna Maria Di Giacomo, Ana de Jesus-Acosta, Jean Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R. Hansen, Sarina A. Piha-Paul, Toshihiko Doi, Bo Gao, Hyun Cheol Chung, Jose Lopez-Martin, Yung Jue Bang, Ronnie Shapira Frommer, Manisha Shah, Razi Ghori, Andrew K. JoeScott K. Pruitt, Luis A. Diaz

Research output: Contribution to journal › Article › peer-review

317 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/ mismatch repair–deficient cancer: Results from the phase II KEYNOTE-158 study'. Together they form a unique fingerprint.

Medicine & Life Sciences